Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Journal of Oncology Practice|March 2, 2011
Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experienceLeonard G Gomella, Jianqing Lin, Jean Hoffman-Censits, et al.European Urology|October 8, 2015
Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor LocationFarzana A Faisal, Debasish Sundi, Jeffrey J Tosoian, et al.International Journal of Radiation Oncology, Biology, Physics|March 8, 2022
Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical TrialLiat Hammer, David Hausner, Maoz Ben-Ayun, et al.International Journal of Radiation Oncology, Biology, Physics|April 13, 2024
Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life ReportJoseph Lombardo, Edward Castillo, Richard Castillo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.International Journal of Radiation Oncology, Biology, Physics|April 6, 2018
Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation TherapyJie Lan, Rui Li, Li-Mei Yin, et al.Urologic Oncology|November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working groupVivek Narayan, Michael Harrison, Heather Cheng, et al.Eclinicalmedicine|May 21, 2026
Celiac plexus radiosurgery for retroperitoneal pain in advanced cancer: a pre-specified secondary analysis of health-related quality of life in a phase II single-arm trialAisling S Barry, Ronen Fluss, Laura A Dawson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 14, 2013
Randomized, multicenter, phase II study of CO-101 versus gemcitabine in patients with metastatic pancreatic ductal adenocarcinoma: including a prospective evaluation of the role of hENT1 in gemcitabine or CO-101 sensitivityElizabeth Poplin, Harpreet Wasan, Lindsey Rolfe, et al.BMC Cancer|July 1, 2017
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)Noura Radwan, Ryan Phillips, Ashley Ross, et al.Pageof 4